OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update…
Cannabix Technologies announces Stock Option Grant and Director Resignation
March 14, 2025 18:15 ET | Source: Cannabix Technologies Inc. VANCOUVER, British…
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024
March 11, 2025 16:05 ET | Source: SIGA Technologies Inc. Increased Product…
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
– Company generated quarterly sequential growth in YCANTH® dispensed applicator units of…
MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
ROCKVILLE, Md., March 11, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT;…
LifeMD Reports Fourth Quarter 2024 Results
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up…
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”)…
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025 16:30 ET | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO,…
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
March 05, 2025 17:52 ET | Source: Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass.,…
Blueprint Digital Marketing and Trusted Experts Unveil Tips to Safely Choose Home Services & Wellness Providers
CALGARY, Alberta, March 04, 2025 (GLOBE NEWSWIRE) -- Blueprint Digital Marketing, in…